Ładuje się......
Initial treatment for patients with chronic myeloid leukemia
The first-line treatment of chronic myeloid leukemia is based on the three currently available tyrosine kinase inhibitors (TKIs), namely imatinib, nilotinib and dasatinib. Nilotinib and dasatinib are more potent, and it is predicted that, in comparison with imatinib, they can reduce the risk of prog...
Zapisane w:
| Wydane w: | Leukemia Suppl |
|---|---|
| 1. autor: | |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Nature Publishing Group
2012
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4851202/ https://ncbi.nlm.nih.gov/pubmed/27175245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leusup.2012.21 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|